Learning Skills Together Pilot Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04428034 |
Recruitment Status :
Completed
First Posted : June 11, 2020
Results First Posted : March 4, 2022
Last Update Posted : March 21, 2023
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Family Caregiving Complex Care Self Efficacy Intervention | Behavioral: Learning Skills Together | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 41 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | A pre- and post-test design to test the Learning Skills Together program will be employed. |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | A Pilot Evaluation of Learning Skills Together: A Intervention to Teach Complex Care Skills to Caregivers of Persons Living With Alzheimer's Disease |
Actual Study Start Date : | September 3, 2020 |
Actual Primary Completion Date : | August 15, 2021 |
Actual Study Completion Date : | September 9, 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: Learning Skills Together Intervention
Participants in the Learning Skills Together program will begin their participation with a one-on-one phone call with an interventionist, who will ensure the participant is prepared to to attend the group sessions (e.g., familiar with videoconference technology) and will help the participant to set individual goals. The caregiver participant will then attend 4, group-based sessions lasting approximately 1.5 hours each, to learn about common complex care tasks managed by family caregivers to someone with mid-stage Alzheimer's disease, such as managing behavioral symptoms of dementia, incontinence, nutrition, transferring, medication management, and more. Sessions will integrate interactive activities, such as videos, case studies, and discussions. Approximately four weeks later, caregivers will be asked to attend a group reflection session to discuss application of what was learned and progress in meeting individual goals.
|
Behavioral: Learning Skills Together
Information provided in arm/group description. |
- Change in Caregiver Competency [ Time Frame: Change from baseline to 4 weeks post-intervention; and to 8 weeks post-intervention ]This will be measured using the Caregiving Competence Scale. This measure includes 3-items pertaining to caregiver's confidence (e.g., "I feel confident that I am meeting the needs of my relative"). There are five response options to each statement ("Strongly Disagree" [1] to "Strongly Agree" [5]), such that scores may range from 3 to 15. A lower score indicates a lower level of confidence that the caregiver is meeting their relative's needs (i.e., higher scores are better). The outcome measure will use the average change score from baseline scores.
- Change in Caregiver Mastery [ Time Frame: Change from baseline to 4 weeks post-intervention; and to 8 weeks post-intervention ]This will be measured using the Caregiver Mastery Scale. This 7-item scale asks participants the extent to which they feel they have control over various parts of their lives (e.g., "I have little control over the things that happen to me"). Participants may respond that they "Strongly Disagree (1) to Strongly agree (4) with each statement, such that scores range from 7 to 28. The lower the score, the less control the caregiver feels that they have control (i.e., higher scores are better). The mean score for this measure among caregivers to frail older adults was previously reported as 19.42 (SD 3.29), with Cronbach's alpha of 0.78. The outcome measure will use the average change score from baseline scores.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | All genders are eligible. Gender is self-reported. Participants may select "Male," "Female," and "Other" gender, and may select all responses that apply. |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Family member (including families of choice) to an individual living with Alzheimer's disease who has received a diagnosis from a physician
- Ages 18 and old
- Provides assistance with at least two instrumental activities of daily living or one activity of daily living
- Care recipient is described as being within mid-stage Alzheimer's Disease
- There are no plans to place the care recipient in a skilled nursing facility within the next 3 months
Exclusion Criteria:
- The caregiver is paid to provide care
- The caregiver does not have reliable access to a computer and internet
- The caregiver is unable to read and speak English

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04428034
United States, Texas | |
UT Health San Antonio | |
San Antonio, Texas, United States, 78229 |
Principal Investigator: | Carole L White, PhD, RN | UT Health San Antonio |
Documents provided by The University of Texas Health Science Center at San Antonio:
Responsible Party: | The University of Texas Health Science Center at San Antonio |
ClinicalTrials.gov Identifier: | NCT04428034 |
Other Study ID Numbers: |
HSC20200410H |
First Posted: | June 11, 2020 Key Record Dates |
Results First Posted: | March 4, 2022 |
Last Update Posted: | March 21, 2023 |
Last Verified: | March 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | De-identified study data will be made available to other researchers if requested. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |